LIM and cysteine-rich domains 1 (LMCD1) regulates skeletal muscle hypertrophy, calcium handling, and force

Abstract

BackgroundSkeletal muscle mass and strength are crucial determinants of health. Muscle mass loss is associated with weakness, fatigue, and insulin resistance. In fact, it is predicted that controlling muscle atrophy can reduce morbidity and mortality associated with diseases such as cancer cachexia and sarcopenia.MethodsWe analyzed gene expression data from muscle of mice or human patients with diverse muscle pathologies and identified LMCD1 as a gene strongly associated with skeletal muscle function. We transiently expressed or silenced LMCD1 in mouse gastrocnemius muscle or in mouse primary muscle cells and determined muscle/cell size, targeted gene expression, kinase activity with kinase arrays, protein immunoblotting, and protein synthesis levels. To evaluate force, calcium handling, and fatigue, we transduced the flexor digitorum brevis muscle with a LMCD1-expressing adenovirus and measured specific force and sarcoplasmic reticulum Ca2+ release in individual fibers. Finally, to explore the relationship between LMCD1 and calcineurin, we ectopically expressed Lmcd1 in the gastrocnemius muscle and treated those mice with cyclosporine A (calcineurin inhibitor). In addition, we used a luciferase reporter construct containing the myoregulin gene promoter to confirm the role of a LMCD1-calcineurin-myoregulin axis in skeletal muscle mass control and calcium handling.ResultsHere, we identify LIM and cysteine-rich domains 1 (LMCD1) as a positive regulator of muscle mass, that increases muscle protein synthesis and fiber size. LMCD1 expression in vivo was sufficient to increase specific force with lower requirement for calcium handling and to reduce muscle fatigue. Conversely, silencing LMCD1 expression impairs calcium handling and force, and induces muscle fatigue without overt atrophy. The actions of LMCD1 were dependent on calcineurin, as its inhibition using cyclosporine A reverted the observed hypertrophic phenotype. Finally, we determined that LMCD1 represses the expression of myoregulin, a known negative regulator of muscle performance. Interestingly, we observed that skeletal muscle LMCD1 expression is reduced in patients with skeletal muscle disease.ConclusionsOur gain- and loss-of-function studies show that LMCD1 controls protein synthesis, muscle fiber size, specific force, Ca2+ handling, and fatigue resistance. This work uncovers a novel role for LMCD1 in the regulation of skeletal muscle mass and function with potential therapeutic implications.

Combined Microscopic and Metabolomic Approach to Characterize the Skeletal Muscle Fiber of the Ts65Dn Mouse, A Model of Down Syndrome

“…Further, in the myocardium of persons with DS, cells were found to be enlarged in comparison to controls (Recalde et al, 1986). Interestingly enough, several studies showed that some proteins codified by genes located in the so-called Down Syndrome Critical Region (DSCR) are involved in the calcineurin-NFAT signaling (Rothermel et al, 2003; Arron et al, 2006; Gwack et al, 2006), which regulates a hypertrophic pathway in myofibers (Dunn et al, 1999; Semsarian et al, 1999; Ferreira et al, 2019) and cardiomyocytes (Molkentin et al, 1998). Such a pathway undergoes destabilization in DS (Arron et al, 2006).…”

Isoquercitrin Delays Denervated Soleus Muscle Atrophy by Inhibiting Oxidative Stress and Inflammation

“…Skeletal muscle comprises approximately 40% of the total body weight. Maintenance of skeletal muscle homeostasis is essential for maintaining the body's various functions (Ferreira et al, 2019;Yamakawa et al, 2020). An imbalance in skeletal muscle homeostasis can cause skeletal muscle hyperplasia or atrophy.…”

X chromosome-dependent disruption of placental regulatory networks in hybrid dwarf hamsters

“…1992; Li et al . 2009; Malabanan and Blind 2016), and transcriptional regulation (Ferreira et al . 2019).…”

“…Similarly, the Plexin domain containing 2 gene (Plxdc2) encodes an endothelial cell-surface transmembrane receptor (Cheng et al 2014) that is often co-expressed with Wnt signaling genes (Miller et al 2007). Other candidate hub genes play roles in cell-cell adhesion and differentiation (Wilson et al 2007;Jang et al 2016;Zakaria et al 2019), immune function (Astarita et al 2012;Li et al 2013;Wang et al 2013;Chistiakov et al 2017), nutrient metabolism and delivery (Schmidt et al 1992;Malabanan and Blind 2016), and transcriptional regulation (Ferreira et al 2019).…”